Navco Pharmaceuticals Inc (NAV) Stock Price & News

All values in CAD	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	34,77 миң	2,06 миң	2,95 миң	1,58 миң
Operating expense	34,77 миң	2,06 миң	2,95 миң	1,58 миң
Total operating expenses	34,77 миң	2,06 миң	2,95 миң	1,58 миң
Operating income	-34,77 миң	-2,06 миң	-2,95 миң	-1,58 миң
Other non operating income	-2,27 миң	-1,16 миң	-10,54 миң	-1,91 миң
EBT including unusual items	-39,64 миң	-5,83 миң	-16,55 миң	-6,82 миң
EBT excluding unusual items	-39,64 миң	-5,83 миң	-16,55 миң	-6,82 миң
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-39,64 миң	-5,83 миң	-16,55 миң	-6,82 миң
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-2,61 миң	-2,61 миң	-3,06 миң	-3,33 миң
Net interest expenses	-2,61 миң	-2,61 миң	-3,06 миң	-3,33 миң
Depreciation and amortization charges	-	-	-	-
EBITDA	-26,38 миң	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance